Description
PT-141, also known by its research designation Bremelanotide, is a synthetic peptide analog of α-melanocyte-stimulating hormone (α-MSH). Structurally derived from Melanotan II, PT-141 is designed to selectively activate melanocortin receptors, with primary affinity for MC4R and secondary activity at MC1R. This investigational compound is supplied in a 10 mg lyophilized format for preclinical research applications exploring neuroendocrine signaling and immune modulation.
Reviews
There are no reviews yet.